Eckert & Ziegler SE (FRA:EUZ)

Market Cap	1.01B
Revenue (ttm)	295.85M
Net Income (ttm)	33.28M
Shares Out	n/a
EPS (ttm)	1.59
PE Ratio	30.45
Forward PE	n/a
Dividend	5.15 (11.47%)
Ex-Dividend Date	Oct 3, 2024

Volume	n/a
Average Volume	257
Open	48.30
Previous Close	49.20
Day's Range	48.30 - 48.30
52-Week Range	32.50 - 61.70
Beta	n/a
RSI	39.39
Earnings Date	Mar 27, 2025

About Eckert & Ziegler SE

Eckert & Ziegler SE manufactures and sells isotope technology components worldwide. It operates through two segments, Medical and Isotope Products. The company provides small implants for the treatment of prostate cancer seeds; and eye applicators based on ruthenium-106 and iodine-125 for the treatment of uveal melanomas; brain seed, HDR and brachytherapy; ophthalmological products; therapeutic and radiotherapy accessories, X-Ray therapy, GA-68 generators, radiochromatography, hot cells; and radiopharmaceuticals, laboratory equipment, radiosynt...

• Industry: Industrial Inorganic Chemicals
• Founded: 2024
• Employees: 1,075
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: EUZ

Financial Performance

In 2024, Eckert & Ziegler SE's revenue was 295.85 million, an increase of 20.22% compared to the previous year's 246.09 million. Earnings were 33.28 million, an increase of 26.52%.